Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Gotcha. Well fingers crossed these research partners are impressed with the accuracy. Also I keep checking insider trading and only automatic sells in the last 3 months which is good. No purchases though.
I've been bullish on Endra for a couple years now, but as we await further news about FDA and in light of the recent Colorado and European university collaborations, do you guys recall seeing any independent data showing TAEUS efficacy compared to the current standard of care (MRI)? Is there any possibility that these universities come back and say, "Nope, sorry your product is not sufficient at determining liver fat in an acceptable manner"? I do recall seeing something that they had data based on their protoype and ENDRA saying that the commercialized product would be even better and more accurate than their prototype.
Pumped about this, was making me nervous prior to the run-up.
Seriously! You can set your watch to it.
Any thoughts as to why?
Really strong trading day today and great volume. Thoughts as to why other than overall the industry seems to be doing well under Biden?
Ugh.... lost all our momentum. I'm in it for the long haul, scared money don't make money.
I'm jazzed up right now. Where's the news?? No way this type of volume is just from the conference or the patent issued last week.
Wow, huge run up at end of day. Love this momentum!
Finally! Hopefully the Wainwright conference turned a lot of attendees into buyers.
Might not have been anything groundbreaking. Maybe the attendees at the conference were impressed with the technology, patents, prospects, etc... and jumped on it?
No clue, but love being over a dollar as well as the volume!!
Nice little spike at the end of the day today up to $.85!?!?
Surprised no activity here given the runup. Looking to enter a position here, difficult given the share price $50+ but feel like I'll be kicking myself this time next year if I don't. Curious what the pulse is here on the boards and any other solar positions you guys like?
I think the run up a few weeks ago was very encouraging. I'm sitting pat for now, already have a sizable position that I'm not exactly comfortable with. As they say, "Scared money don't make money"!
Love to see this, good luck longs!
Nice to hear about the Vietnam news today. We seem to be trending in the right direction!
It's definitely more than just today though. Seems to happen often... weird.
Certainly not ideal, but doesn't seem like these funds that sold off were any substantial holdings or positions.
You guys notice at all that it seems every morning we've got a spike in SP and then is quickly comes crashing down? Even with good news today... just seems like a recurring theme that price starts high most mornings or even end of day and then there's a selloff. Curious your thoughts...
That's awesome, thanks for sharing. Like that trend!
Love it. I'm long and excited about the presentation and the potential!
I thought it was a great presentation and mgmt did a good job of explaining the product, the need within the industry, and how they plan to go about positioning themselves as a cost effective point of case resource for clinicians. What I don't know and I think what scares me is the accuracy of efficacy % of their product and whether or not it's tolerable within the industry. I also found it interesting that CEO said their actual install at Rocky Mountain Vista would be better than their "prototype". Would have been nice for him to elaborate how the TAEUS installed at Rocky Mountain was superior.
Did anyone else notice that he referenced what I believe is Rocky Mountain Vista being in Utah? It's in CO, he should know that.
Market cap is SCARY low which is very concerning. Also would have liked them to touch upon the NASDAQ compliance issue and how they intend to get back into compliance. Does anyone know when they have until?
What the hell is going on with this today?!?
Not at all Jugs, they're his shares he can do what he pleases with them. The only reason for my mention was to ask is this a sign of how he views the the future share price down the road?
Anyone else see that Michael Perry sold just under $900K worth of shares in mid Sept??
This is niiiiice!
ANN ARBOR, MI / ACCESSWIRE / November 12, 2020 / ENDRA Life Sciences Inc. ("ENDRA") (NASDAQ:NDRA), a developer of enhanced ultrasound technologies, today announced that Rocky Vista University College of Osteopathic Medicine ("RVUCOM") has begun scanning patients in its clinical study of ENDRA's Thermo-Acoustic Enhanced Ultrasound (TAEUS?) clinical system to assess Non-Alcoholic Fatty Liver Disease ("NAFLD"). The studies are being conducted at RVUCOM's Ivins, Utah location will be the first real-world cases to be performed with TAEUS in the U.S.
ENDRA has received the CE mark to sell the TAEUS system in Europe, and is awaiting clearance by the U.S. Food and Drug Administration for its 510(k) application to begin sales in the U.S. The data from the RVUCOM study, along with other announced and future studies, will be used to further build the clinical evidence base and establish the clinical utility of the TAEUS system in patients with NAFLD to support current and future commercialization efforts.
The goals of the RVUCOM study, include:
Comparing results obtained with ENDRA's commercial design TAEUS liver device against a baseline measure of liver fat as determined by MRI-PDFF (magnetic resonance imaging proton density fat fraction);
Scanning a target of 200 volunteers including fatty liver patients and healthy controls to contribute additional diversity and volume of patient data; and,
Providing ENDRA with ongoing clinical feedback regarding TAEUS product design, clinical workflow and clinical performance.
The principal investigator in the RVUCOM study, Jing Gao, M.D., who is a member of ENDRA's scientific advisory board ("SAB"), commented, "This is an exciting step for ENDRA and for Rocky Vista University as we advance use of the TAEUS platform in a real-world clinical setting. We believe TAEUS has the potential to address a significant unmet clinical need for the robust, practical, non-invasive assessment of liver fat."
"Working with RVUCOM and other leading clinical reference sites is an essential part of building our base of clinical evidence to support commercialization efforts for TAEUS," said ENDRA Chief Commercial Officer Renaud Maloberti. "We look forward to supporting and learning from RVUCOM, as well as other medical facilities that will be evaluating TAEUS."
Which institutions and what type of volume are you seeing? Please share!
Nice little run to close out the week!
Very nice! I've kept adding as it's been dropping. Getting to an uncomfortable place however with how much I'm holding. Scared money don't make money!
Where is this from?
What the hell's going on here today boys!? No news, high volume, way down!!
Crickets here, huh? You guys still optimistic on NDRA? I'm starting to get concerned about the lack of news as well as how many days sub $1 with the potential to get de-listed by the NASDAQ
Hit the nail on the head Gary!
Just initiated at STRONG BUY by Raymond Jones!!
New to this board but seems to be a promising company with a lot of upside!
Great info and read on it, thank you!
I always value your opinion, so much appreciated!!
Do you think the market is not impressed with these figures and they're not "gold standard" enough to be a disrupter? Also, thoughts on the recent exercise of warrants generating $5 mill for the company? Said that ENDRA "accepted reduced exercise prices".
Anyone out there monitoring this company? seems to be some activity on the Canadian boards.
Who else is long here and what are your thoughts about this company? Seems like it has nice upside with potential in the Portugal market.